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Rapid antibiotic susceptibility testing using
resazurin bulk modified screen-printed
electrochemical sensing platforms†
Benjamin Crane, Jack P. Hughes, Samuel J. Rowley Neale, Mamun Rashid,
Patricia E. Linton, Craig E. Banks * and Kirsty J. Shaw *
Urinary tract infections (UTIs) are one of the most common types of bacterial infection. UTIs can be
associated with multidrug resistant bacteria and current methods of determining an effective antibiotic
for UTIs can take up to 48 hours, which increases the chances of a negative prognosis for the patient. In
this paper we report for the first time, the fabrication of resazurin bulk modified screen-printed macro-
electrodes (R-SPEs) demonstrating them to be effective platforms for the electrochemical detection of
antibiotic susceptibility in complicated UTIs. Using differential pulse voltammetry (DPV), resazurin was
able to be detected down to 15.6 µM. R-SPEs were utilised to conduct antibiotic susceptibility testing
(AST) of E. coli (ATCC® 25922) to the antibiotic gentamicin sulphate using DPV to detect the relative con-
centrations of resazurin between antibiotic treated bacteria, and bacteria without antibiotic treatment.
Using R-SPEs, antibiotic susceptibility was determined after a total elapsed time of 90 minutes including
the inoculation of the artificial urine, preincubation and testing time. The use of electrochemistry as a
phenotypic means of identifying an effective antibiotic to treat a complicated UTI offers a rapid and accu-
rate alternative to culture based methods for AST with R-SPEs offering an inexpensive and simpler alterna-
tive to other AST methods utilising electrochemical based approaches.
Introduction
Urinary tract infections (UTIs) are one of the most common
types of infection caused by bacteria;1 there is also evidence to
suggest that the number of hospital admissions due to UTIs in
the UK is increasing.2 UTIs can be broadly split into two cat-
egories: uncomplicated and complicated UTIs. Uncomplicated
UTIs are typically associated with individuals who do not have
any structural or neurological issues of the urinary tract and
are otherwise healthy,3 while complicated UTIs are infections
that occur in individuals who are structurally or immunologi-
cally compromised in some way, with examples being renal
failure or immunosuppression.4
The majority of uncomplicated and complicated UTIs are
caused by Escherichia coli (E. coli).1,5 The E. coli associated
with complicated UTIs can be either single- or multidrug-
resistant which limits effective antibiotic treatment options.3
The principle issue with progressive colonisation of the
urinary tract by antibiotic resistant bacteria is that it may lead
to the infection of the kidneys which can progress to bacterae-
mia.1 Bacteraemia results in urosepsis which accounts for 25%
of all adult sepsis cases and carries a morality rate of 25 to
60%.6 This highlights the importance of identifying effective
antibiotics to treat UTIs, especially regarding complicated
UTIs.
Following the diagnosis of a UTI through the presentation
of clinical symptoms,7–9 or the use of a dipstick,10 antibiotic
susceptibility testing (AST) is performed in order to assess the
type of antibiotic a pathogenic bacteria may be susceptible to.
Whilst AST is being conducted, it is common for patients to be
treated with general broad-spectrum antibiotics until the
results are available.11 This can lead to further deterioration in
cases caused by strains resistant to such antibiotics, poten-
tially leading to poor clinical outcomes for patients.12
Additionally this practice in prescribing a potentially in-
effective antibiotic is a major contributor to the further devel-
opment of antibiotic resistance in pathogenic bacterial
strains.13,14
AST can be phenotypic or genotypic. Phenotypic testing
directly determines antibiotic susceptibility and typically uses
a culture-based methodology to monitor the response in bac-
terial growth to different antibiotics. Although accurate,
culture-based methods are time consuming, taking between
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one to three days to sufficiently grow the bacterial culture and
for AST to be conducted.15,16 Genotypic testing offers an alterna-
tive and utilises amplification and identification of known
genes, which confer antibiotic resistance, to accurately identify
which antibiotics would be ineffective against a bacterial strain
type. One of the limitations of genotypic testing is that it relies
on a time consuming pre-incubation step which can take up to
four hours to grow the bacterial population in addition to the
testing time.16 Additionally, it is impossible to identify all of the
resistance genes which are numerous and subject to frequent
changes due to mutations,17 in addition the presence of a resis-
tance gene may not confer phenotypic resistance making geno-
typic testing potentially unreliable.18 A faster method of con-
ducting AST could potentially help reduce or eliminate the pre-
scription of ineffective broad-spectrum antibiotics.
Resazurin is a redox indicator that has a documented history
of use in cell viability assays.19 Resazurin can be biologically
reduced by metabolically active aerobic bacteria to form resoru-
fin, and then reduced again to form dihydroresorufin.16,20
Conventional resazurin AST assays confirm the presence of live
cells based off the detection of resorufin21–23 and can be carried
out optically (using absorbance or fluorescence) or electroche-
mically. For example, Avesar et al., created a biosensor contain-
ing a stationary nanolitre droplet array for measuring pro-
duction of the fluorescent resorufin product at 30 minutes time
intervals for AST of different bacteria strains.23
The electrochemical mechanism of resazurin has been
extensively studied in both aqueous solutions and ionic
liquids using glassy carbon electrodes.20 An electrochemically
based approach for resazurin based phenotypic AST offers a
more sensitive method as resazurin can be detected directly
rather than relying on an extended incubation period to
enable resorufin concentrations to increase to detectable
levels. Rapid AST has been demonstrated using organic redox-
active crystalline layers on pyrolytic graphite sheets which
enables accurate determination on minimum inhibitory con-
centrations (MIC) of antibiotics in as little as 60 mins.25
Microfabricated systems, for example, a three-dimensional
interdigitated electrode array with impedimetric transducer,
have shown how integration of the components required for
AST can be achieved.19 While resazurin is heavily used in such
systems for AST, other indicators are also available, such as fer-
ricyanide which is reduced to ferrocyanide during bacterial res-
piration and has been investigated for amperometric assays.26
Screen-printed macroelectrodes (SPEs) present a variety of
useful qualities such as being versatile, highly reproducible
with the ability to be mass produced and can be utilised in
either surface modified or bulk modified configurations26–28
For example, gold SPEs, modified with hydrogels containing
antibiotics and growth media showed bacterial growth could
be monitored using both electrochemical impedance spec-
troscopy (EIS) and differential pulse voltammetry (DPV).29
SPEs have been utilised as part of a surface modified resazurin
based detection method however,30 the use of SPEs as a plat-
form for resazurin based AST has not yet been fully explored.
The use of a simple method for the bulk-modification of SPEs
that is part of the SPE fabrication process would reduce
the time and complexity in the steps required for the produce
of a set of modified SPEs whilst maintaining effectivity.
Consequently, in this paper, we report for the first time, the
bulk modification of SPEs with resazurin which are applied to
the AST of UTI causative bacteria. Fig. 1 shows a schematic
overview of the phenotypic AST using an electrochemical
based sensing methodology.
Experimental section
All chemicals used in this work were of analytical grade, some
of the resulting solutions that were made up required sterilisa-
tion treatment before use as detailed below. Resazurin solutions
were made every day prior to use. All solutions were prepared
using water or dissolved in a suitable supporting electrolyte
solution, using water purified using a Millipore Milli-Q system
(Type 1 Ultrapure water, 18.2 MΩ cm at 25 °C). Potassium phos-
phate monobasic (KH2PO4), potassium chloride (KCl), surine,
gentamicin sulphate and resazurin sodium salt were all
obtained from Sigma-Aldrich (Gillingham, UK). Nutrient broth
(CM0001) and nutrient agar (CM0003) were obtained from
Thermo Scientific (Oxoid, UK). A HI 2209 pH meter obtained
from Hanna instruments (Leighton Buzzard, UK) was utilised.
For overnight cultures, single strength nutrient broth was
also made up according to manufacturer’s instructions (Oxoid,
13 g to 1 L distilled water) and autoclaved. Artificial urine
broth was made up using an equal volume of surine and
double strength nutrient broth which was adjusted to a pH of
6. Artificial urine was autoclaved at 121 °C for 20 minutes to
sterilise the solution before use. A stock solution of the anti-
biotic gentamicin sulphate was made up at a concentration of
96 mM in sterile deionised water before being filter sterilised
using a 45 nm syringe filter. All experiments were performed
at room temperature without oxygen removal.
E. coli (ATCC® 25922) was grown on nutrient agar from a
stock kept in freezer storage and incubated at 37 °C for
24 hours. Overnight cultures were prepared from these plates
using one colony taken from the plates to inoculate 10 mL of
single strength nutrient broth and incubated at 37 °C for a
further 24 hours.
Electrochemical measurements
Electrochemical measurements utilised an EmStat3 potentio-
stat controlled by PSTrace 5.5 software utilising an EmStat
three pin SPE connector as the interface between the electrode
and the potentiostat all sourced from PalmSens (The
Netherlands, Randhoeve). The electrochemical measurements
were utilised using a three-electrode configuration, having a
graphite working electrode acting as both the counter and
reference electrode. Cyclic voltammetry was conducted using a
potential range of 0 to −0.65 V, an E-step of 0.005 V and the
following scan rates: 0.005, 0.01, 0.015, 0.025, 0.050, 0.075,
0.100, 0.150 and 0.200 V s−1. Differential pulse voltammetry
(DPV) was carried out using a potential range of 0 V to −1.4 V,
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an E-step of 0.001 V, a T-pulse of 0.05 s, an E-pulse of 0.05 V
and a scan rate of 0.01 V s−1. A buffered supporting electrolyte
solution (BSES) made up of 1.5 mM KH2PO4 and 0.1 M KCl
was made up for the purpose of testing the unmodified/bare
SPEs using cyclic voltammetry.
In order to test the R-SPEs using artificial urine and to
conduct the limit of detection experiments a micro-dropping
(µDrop) methodology was used to emulate the type of volume
that would be used for the AST method. µDrop involved pipet-
ting a 60 µL volume of the chosen sample onto the SPE to cover
the working, counter, and reference electrodes completely.
Fabrication of the screen-printed macroelectrodes (SPEs) and
resazurin bulk modified screen-printed macroelectrodes
(R-SPEs)
The SPEs were fabricated by screen-printing a carbon-graphite
ink (product code: C2000802P2; Gwent Electronic Materials
Ltd, UK) layer onto a polyester substrate (Autostat, 250 µm
thickness) using a DEK 248 screen-printing machine (DEK,
Weymouth, UK). This layer was then cured using a fan oven set
to 60 °C for a duration of 30 minutes. This defines the working
electrode (3.1 mm), counter and reference electrodes as well as
the connection points for the SPE to be interfaced with the
EmStat three pin SPE connector to facilitate electrochemical
readings. After curing, the connections were sealed with a
dielectric paste (product code: D2070423D5; Gwent Electronic
Materials Ltd, UK) to isolate the working area of the SPE made
up by the working, counter, and reference electrode from the
connection points. Then the SPEs were cured again at 60 °C
for 30 minutes before being ready to use.
The R-SPEs were made by modifying the carbon-graphitic
ink via modification with resazurin. This was carried out using
a weight percentage of MP to MI, where MP is the mass of par-
ticulate (the mass of resazurin) and MI is the total mass of the
ink including the base graphitic ink and the mass of the
particulate.31–34 This was thoroughly mixed into the ink and
screen-printed on top of the carbon-graphite working elec-
trode. The equation (MP/MI) × 100 was used to formulate the
10 wt% R-SPEs. A 10 wt% of resazurin was used to ensure con-
sistent printing of the analyte in the fabrication process and to
test viability of the proposed electrochemical AST system.
Detecting bacterial growth in response to different antibiotic
concentrations
To establish that differences in growth rate can be detected in
E. coli at different concentrations of gentamicin using electro-
chemical methods, an overnight culture was adjusted to an
optical density of 0.7 at 600 nm post incubation using single
strength nutrient broth as the diluent. After which 12.5 µL of
the standardised solution was added to a total volume of
500 µL artificial urine in a bijou to produce an initial bacterial
concertation of 1.76 × 107 CFU mL−1. A CFU mL−1 count of
≥105 is taken as confirmation of A UTI,10 an initial count of
1.76 × 107 CFU mL−1 was used to simulate a severe infection.
The resulting inoculated solution was then vortexed and prein-
cubated at 37 °C for 70 minutes on a shake plate bringing the
bacterial population to exponential growth phase (see ESI
Fig. S1†) and producing a bacterial concentration of 1.75 × 108
CFU mL−1, the antibiotic was then added. The inoculated arti-
ficial urine was vortexed again, and the µDrop method was
Fig. 1 An overview schematic of phenotypic AST using an electrochemical based sensing methodology. Resazurin can be reduced intracellularly by
metabolically active bacteria or electrochemically at the surface of the working electrode which allows the antibiotic susceptible and antibiotic
resistant bacteria to be determined.20,24
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used. Bacteria were freely suspended in the artificial urine and
not immobilised on the electrodes. The chosen electro-
chemical method (cyclic voltammetry or differential pulse vol-
tammetry) was then used to generate a resazurin reduction
peak at hour zero. Between readings, the resazurin infused
artificial urine was incubated at 37 °C. Electrochemical
measurements were taken every hour for four hours.
Statistical analysis
Statistical analysis was conducted using R (Version 3.5.3) with
the R studio add-on (Version 1.2.5033) using 95% confidence
limits. Normality of a dataset was assessed using a Shapiro–
Wilk test. When comparing two data sets normally distributed
data was analysed with a T-test or a Wilcoxon rank test if nor-
mality was not determined.
Results and discussion
First, cyclic voltammetric responses for 1 mM resazurin (in pH
6 buffered supporting electrolyte solution (BSES)) were
explored to determine the electrochemical mechanism using
bare/unmodified screen-printed electrochemical sensing plat-
forms. As shown within Fig. 2, voltammetric responses gives
rise to two electrochemical reduction peaks and a single oxi-
dation peak. From previous work on glassy carbon electro-
des,20 we attribute the cathodic peak at C1 corresponding to
the electrochemical irreversible reduction of resazurin to resor-
ufin, while C2 corresponds to the electrochemical quasi-irre-
versible reduction of resorufin to dihydroresorufin and the
anodic peak at A1 corresponds to the electrochemical oxi-
dation of dihydroresorufin to resorufin. The height of the resa-
zurin reduction peak height (IH, C1) was explored as a function
of scan rate where a plot of IH vs. the square-root of scan rate
was found to be linear. Further analysis in the form of a plot
of log peak current versus log scan rate (log Ip/µA = 0.43 µA/V
s−1 + 0.77 µA) indicated a gradient of 0.4 close to the theoreti-
cally expected 0.5 for a diffusion-controlled process.
Next, the effect of pH was explored, where the voltammetric
profiles were explored as a function of pH. A plot the resazurin
reduction peak position (Ep) using the voltametric peak at C1
was plotted vs. pH. Noting that the pKa of resazurin is 6.71 (at
25 °C),35 a linear trend was observed after which with an
increase in pH causing a shift in Ep to a more negative value.
The shift in the Ep value is due to the participation of protons
in the electrochemical reduction of resazurin to resorufin
which can be described with the following equation:
Ep ¼ E0formal 
2:303RTm
nF
pH ð1Þ
where Ep [V] is the peak potential, E0formal [V] is the formal
potential of the redox couple, R [J K−1] is the universal gas con-
stant, T [K] is the temperature and m and n are the number of
protons and electrons involved in the redox process.36 The plot
of Ep as a function of pH yields a slope of 65.7 mV pH
−1 which
is close to the theoretical expected slope for an equal proton
and electron process in agreement with the mechanism pre-
sented in Fig. 1.
Fig. 3A shows typical DPV responses of both the R-SPEs and
bare SPEs. Both electrode types produce a single cathodic peak
(C1), which is likely due to the resazurin and resorufin
reduction peak have become amalgamated which has been
previously observed when using DPV and gold working,
counter and reference electrodes to detect resazurin in artifi-
cial urine where the bulk of the reduction peak height corres-
ponds to resazurin reduction.16 In comparing the DPV as
shown in Fig. 3, note that in the case of the R-SPEs compared
to the bare SPEs, both are different electrochemical systems.
In the later, resazurin is added into the solution such that the
concentration is high resulting in a large voltammetric signal.
However, in the case of the latter, the peak is smaller and not
as well-defined due to the fact that the resazurin is lower in
concentration within the bulk of the SPE and likely a dual pro-
cesses of dissolution and surface electrochemistry is in oper-
ation. That said, the R-SPE simplify the system.
Next, DPV was explored within artificial urine. Artificial
urine was used in place of a BSES to better emulate the con-
ditions of a urine sample and thus gain better insight into
how sensitive DPV is in detecting resazurin in real world urine
samples. Artificial urine of pH 6 was used as the normal pH
range of urine is pH 4–8 with an average skewed towards acidic
values,38 therefore pH 6 was chosen as the physiological pH
value. DPV was chosen as the electroanalytical technique due
to its sensitivity,37 and rapid speed of analysis.
Fig. 3B shows the DPV peak height response of bare SPEs to
a range of resazurin concentrations (0.0156–1 mM) using artifi-
cial urine and µDrop. A plot of analytical signal (Ip, C1) vs. resa-
zurin concentration revealed that as the concentration was
increased the magnitude of the analytical signal increased (see
ESI Fig. S2†). The lowest tested concentration (LTC) of resazurin
Fig. 2 Typical cyclic voltammograms (CVs) recorded in the presence
(solid line) and absence (dashed line) of 1 mM resazurin in pH 6 BSES
using a bare SPE. Scan rate: 100 mV s−1. The arrow indicates the direc-
tion of the voltametric scan.
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was 15.6 µM. Plotting the reduction peak height as a function
of concentration produced a nonlinear trend, as such the fol-
lowing equations were used to estimate the limit of detection:39
LOB ¼ Meanblank þ 1:645 SDblank ð2Þ
LOD ¼ LOBþ 1:645 SDLTC ð3Þ
where LOB is the limit of the blank, SD is standard deviation,
and LTC is the lowest tested concentration in the experiment
(1.56 µM). The mean blank value (2) was derived from the vol-
tammogram response of an unmodified SPE in pH 6 artificial
urine in the absence of resazurin (Fig. 3A). This was done by
recording the any dips in the current in the potential window
wherein reduction could occur. These values were transformed
into molar concentrations using the gradient derived from the
plots of resazurin reduction peak height versus concentration.
Using this approach, the LOD (3) was estimated to be 11 µM
which shows the high analytical sensitivity afforded in
using DPV.
To determine the viability of using R-SPEs in combination
with DPV as a method of conducting AST, R-SPEs were used to
determine the antibiotic susceptibility of E. coli to gentamicin
sulphate. Gentamicin sulphate concentrations in the range of
0.194–2.71 µM were used, with the antibiotic being added after
the initial 70-minute preincubation step. After antibiotic
loading, the artificial urine was added to the R-SPEs via µDrop
and DPV was applied to produce an initial resazurin reduction
peak. Subsequent readings were taken every hour, for up to
four hours. This timing window was chosen to determine how
quickly a significant difference in the resazurin reduction peak
values could be determined to establish feasibility for use in a
point of care setting. Statistically significant results were
obtained at antibiotic concentrations of 1.36 µM and above.
Fig. 4A shows the DPV peak height response of the R-SPEs
using 1.55 and 0 µM concentrations of gentamicin sulphate.
The trend shows that the DPV peak height response of the
antibiotic loaded artificial urine is higher than the control as
significantly less resazurin has been biologically reduced.
The reported MIC of gentamicin sulphate is 0.968 µM (see
ESI Fig. S3†).40,41 MIC testing, however, relies on visual identi-
fication of microbial growth through liquid or agar based cul-
turing not electrochemical detection of an redox marker.
Gentamicin sulphate is an aminoglycoside type antibiotic and
induces bacterial cell death via inhibition of protein syn-
thesis.42 Although cell growth is inhibited at a concentration
of 0.968 µM, the presence of residual protein synthesis can
produce enzymes causing intracellular resazurin reduction.24
Therefore, a higher concentration of gentamicin sulphate than
the MIC was required to inhibit the residual protein synthesis.
For subsequent experiments, a concentration of 1.55 µM was
used to ensure that bacterial protein synthesis was reliably
inhibited. As part of a control we tested if gentamicin sulphate
has a significant effect on the reduction of resazurin as the sul-
phate group may be electrochemically active in the applied
potential range.43 Using the proposed method, the inhibitory
concentration of gentamicin sulphate 1.55 µM was run against
a control of 0 µM in sterile artificial urine using a one-hour
time interval between electrochemical readings. This control
experiment also served to determine if the significant differ-
ence that is observed between resazurin reduction peak
Fig. 3 A: Typical differential pulse voltammograms obtained for R-SPEs (black), bare SPEs with 627 µM resazurin in artificial urine (blue), and bare
SPEs with 0 µM resazurin in artificial urine (green). The reduction peaks (C1) correspond with resazurin reduction. B: Peak height analysis of the peak
labelled C1 for bare SPEs. Each data point is the average of 5 measurements with associated standard deviation.
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heights between the gentamicin sulphate treated and the
untreated artificial urine was due to bacterial metabolism and
subsequent inhibition by the gentamicin, or just due to the
potential electrochemical properties of the sulphate group.
Fig. 4B shows the DPV response of R-SPEs using 1.55 and 0 µM
concentrations of gentamicin sulphate in the absence of bac-
teria. No statistical significance was determined to occur at any
of the time points. Therefore, at a dose of 1.55 µM the antibiotic
gentamicin sulphate had no significant effect on the electro-
chemical reduction of resazurin and any statistically signifi-
cance between the gentamicin sulphate treated and untreated
artificial urine was caused by the metabolic activity of bacteria.
To determine if statistical significance could be determined
faster and to minimise any effect that residual protein syn-
thesis may have on the concentration of resazurin, the use of a
shorter time interval between DPV readings was explored.
Fig. 5 shows the difference in the DPV responses using R-SPEs
and gentamicin sulphate concentrations of 1.55 and 0 µM
using 20-minute time intervals. A statistically significant differ-
ence (paired T test; t = 6.3626, df = 4, p-value = 0.003128)
between the resazurin reduction peak heights generated was
found after 90-minutes of total elapsed time (70-minute pre-
incubation + 20-minute time interval). Using this proposed
method, the most rapid means of determining statistical sig-
nificance using R-SPEs was to take a reading 20-minute after
the 70-minute preincubation step.
Reported in the literature there have been other studies uti-
lising resazurin or electrochemical AST methods (Table 1). The
proposed method is significantly faster in terms of time to
analysis than the disk diffusion assay which is the current gold
standard for culture-based AST as well as the resazurin assay.
The time to analysis is also comparable, or faster than many of
the other electrical and electrochemical methods. The current
limitation is that the proposed method has only been tested
versus E. coli and the antibiotic gentamicin sulphate, however
future work is being undertaken to test the method against
other bacteria and antibiotics. The method is compatible with
Fig. 4 Resazurin reduction peak height at time intervals of; A: one hour with inoculated artificial urine; B: one hour with sterile artificial urine using gen-
tamicin sulphate concentrations of 0 (black) and 1.55 µM (blue). AST DPV was conducted using R-SPEs. Data shown is the average of 5 measurements
and associated standard deviation. Statistical significance between resazurin reduction peaks height at a time interval are marked with a * symbol.
Fig. 5 Resazurin reduction peak height at time intervals of 20 minutes
using gentamicin sulphate concentrations of 0 (black) and 1.55 µM
(blue). AST DPV was conducted using an R-SPE . Data shown is the
average of 5 measurements and associated standard deviation.
Statistical significance between resazurin reduction peaks height at a
time interval are marked with a * symbol.
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any bacteria that can synthesise dehydrogenase enzymes to
biologically reduce resazurin,24 which are ubiquitous amongst
aerobic bacteria, giving the proposed method a high potential
for versatility in AST. Although the presented time to analysis
is slower than some of the methods contemporaries, the sim-
plicity in the fabrication and performance of the R-SPEs
makes them a powerful analytical tool.
The proposed method offers an inexpensive and rapid
alternative to other resazurin based electrochemical detection
systems for antibiotic susceptibility testing with an application
towards urinary tract infections. This proposed system utilises
10 wt% R-SPEs, the percentage of which can be varied to
potentially further decrease the time taken to achieve statisti-
cal significance to further optimise the system and reduce
cost; such work is currently being undertaken.
Conclusions
We have demonstrated that R–SPEs can successfully be used
for the basis of an electrochemical detection system for AST.
The incorporation of resazurin via bulk modification of SPEs
was successfully demonstrated as a viable delivery mechanism
for resazurin in artificial urine. Using DPV, resazurin was able
to be detected down to 15.6 µM. Using the R-SPEs we have suc-
cessfully shown the ability to detect small changes in the con-
centration of resazurin caused by bacterial metabolism. In
using SPEs antibiotic susceptibility was determined in
90 minutes. The method developed here, offers a novel means
of conducting AST using cost-effective and mass-producible
electrochemical sensing platforms for AST which is simpler
and more cost effective than other reported methods.
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